FDA official logo
GSRS logo
PFDA official logo

PEMBROLIZUMAB

  • UNII: DPT0O3T46P
  • Preferred Substance Name: PEMBROLIZUMAB

  • 1374853-91-4
  • IMMUNOGLOBULIN G4, ANTI-(HUMAN PROTEIN PDCD1 (PROGRAMMED CELL DEATH 1)) (HUMAN-MUS MUSCULUS MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LIGHT CHAIN, DIMER
  • KEYLYNK-010 COMPONENT PEMBROLIZUMAB
  • KEYTRUDA
  • LAMBROLIZUMAB
  • MK 7684A COMPONENT PEMBROLIZUMAB
  • MK-1308A COMPONENT PEMBROLIZUMAB
  • MK-3475
  • PEMBROLIZUMAB [INN]
  • PEMBROLIZUMAB [JAN]
  • PEMBROLIZUMAB [MI]
  • PEMBROLIZUMAB [PURPLE BOOK CDER]
  • PEMBROLIZUMAB [USAN]
  • PEMBROLIZUMAB [VANDF]
  • PEMBROLIZUMAB [WHO-DD]
  • PEMBROLIZUMAB COMPONENT OF KEYLYNK-010
  • SCH-900475

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.